← All Sponsors
SPONSOR

Marker Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Acute Myeloid Leukemia, in RelapseMDS
NCT06552416 Phase 1
Recruiting

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

Acute Myeloid Leukemia, in Relapse
United States View Trial →